Larvol Delta - Chronic-Spontaneous-Urticaria-in-the-Era-of-Targeted-Therapy-From-Pathogenic-Mechanisms-to-Precision-Medicine

Xolair (omalizumab) - Roche, Novartis

Dupixent (dupilumab) - Sanofi, Regeneron

http://www.ncbi.nlm.nih.gov/pubmed/42795912

Mirjana Turkalj

Sep 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next